- Report
- July 2024
- 335 Pages
Global
From €4302EUR$4,950USD£3,744GBP
- Report
- May 2024
- 387 Pages
Global
From €4302EUR$4,950USD£3,744GBP
- Report
- February 2025
- 683 Pages
Global
From €4302EUR$4,950USD£3,744GBP
- Report
- October 2023
- 385 Pages
Global
From €4302EUR$4,950USD£3,744GBP
- Report
- March 2024
- 351 Pages
Global
From €4302EUR$4,950USD£3,744GBP
- Report
- September 2023
- 141 Pages
Global
From €1955EUR$2,250USD£1,702GBP
- Report
- September 2024
- 180 Pages
Global
From €1864EUR$2,145USD£1,622GBP
€2868EUR$3,300USD£2,496GBP
- Report
- December 2023
- 220 Pages
Global
From €1864EUR$2,145USD£1,622GBP
€2868EUR$3,300USD£2,496GBP
- Report
- October 2023
- 420 Pages
Global
From €1638EUR$1,885USD£1,426GBP
€2520EUR$2,900USD£2,194GBP
- Drug Pipelines
- August 2023
- 400 Pages
China
From €1695EUR$1,950USD£1,475GBP
€2607EUR$3,000USD£2,269GBP
- Drug Pipelines
- August 2023
- 580 Pages
United States
From €2373EUR$2,730USD£2,065GBP
€3650EUR$4,200USD£3,177GBP
- Report
- September 2022
- 300 Pages
China
From €1695EUR$1,950USD£1,475GBP
€2607EUR$3,000USD£2,269GBP
- Report
- June 2022
- 1500 Pages
Global
From €2203EUR$2,535USD£1,917GBP
€3389EUR$3,900USD£2,950GBP
- Report
- November 2021
- 222 Pages
Global
From €1695EUR$1,950USD£1,475GBP
€2607EUR$3,000USD£2,269GBP
- Report
- July 2020
- 1200 Pages
Japan
From €1695EUR$1,950USD£1,475GBP
€2607EUR$3,000USD£2,269GBP
- Report
- February 2022
- 360 Pages
United States
From €2034EUR$2,340USD£1,770GBP
€3129EUR$3,600USD£2,723GBP
- Report
- October 2021
- 78 Pages
Global
From €695EUR$800USD£605GBP
- Report
- August 2024
- 317 Pages
Global
From €3650EUR$4,200USD£3,177GBP
- Report
- February 2025
- 225 Pages
Global
From €3911EUR$4,500USD£3,404GBP
- Report
- September 2024
- 156 Pages
Global
From €4041EUR$4,650USD£3,517GBP

The Antibody Drug market is a subset of the biotechnology industry that focuses on the development and commercialization of therapeutic antibodies. Antibody drugs are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. These drugs are designed to target specific molecules in the body, such as proteins, hormones, and enzymes, and can be used to block or activate certain pathways. Antibody drugs are typically administered intravenously or subcutaneously, and can be used in combination with other drugs or therapies.
The Antibody Drug market is highly competitive, with many companies investing in research and development to create new and improved treatments. Companies in the market are focused on developing novel antibodies, as well as improving existing treatments. Additionally, companies are investing in the development of biosimilars, which are generic versions of existing antibody drugs.
Some companies in the Antibody Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, Regeneron, Roche, and Sanofi. Show Less Read more